Pharmacyclics, Inc.
Industry
- Biotechnology
- Pharmaceuticals
Latest on Pharmacyclics, Inc.
While early 2023 saw COVID-19 finally fading away, other global crises continued throughout the year (Russia-Ukraine invasion) or were newly created (Israel-Hamas conflict). In short, the socioeconomi
The first court hearing in litigation against the Inflation Reduction Act’s Medicare drug price negotiation program will be a barometer for how the various claims by industry may fare and determine if
Judge Michael Newman asked no questions during the first court hearing on the Inflation Reduction Act’s Medicare price negotiation program but expressed appreciation for the arguments of the attorneys
The first-quarter earnings season’s second week started quietly. A few European pharmaceutical companies reported results before a rush of US and European companies towards the end of the week. AbbVie